Combination Therapy with TZD and SGLT-2 Inhibitor: A Promising Treatment Strategy for Diabetes and Cardiovascular Health
Combination therapy involving a thiazolidinedione (TZD) and an SGLT-2 inhibitor has emerged as a promising strategy for the treatment of diabetes. This approach utilizes the distinct mechanisms of these two drugs to effectively manage blood sugar levels and reduce the occurrence of major cardiovascular complications. At the International Conference of the Korean Diabetes Association (ICDM […]
Study Finds No Increased Risk of Urinary Tract Infections with SGLT2 Inhibitors in Japanese Diabetic Patients
New Study Finds Low Risk of Urinary Tract Infections in Japanese Diabetic Patients Taking SGLT2 Inhibitors The latest breakthrough in diabetes treatment comes in the form of SGLT2 inhibitors, which have shown promising results in lowering blood sugar levels. However, concerns regarding the risk of urinary tract infections have been raised due to the drug’s […]
